Yahoo Web Search

Search results

1. • 

     Duchenne muscular dystrophy drug flunks Phase 3 confirmatory trial

     Endpoints News· 3 hours ago

     NS Pharma’s Duchenne muscular dystrophy drug Viltepso failed its confirmatory study. Despite the...

2. • 

     NS Pharma reports data from Phase III Duchenne treatment trial

     Clinical Trials Arena via Yahoo Finance· 6 hours ago

     The randomised, placebo-controlled study enrolled 77 male patients with DMD who were able to walk....

3. • NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...

     FOX 4 Kansas City· 1 day ago

     Viltolarsen was approved by the United States (US) Food and Drug Administration (FDA) in 2020 under the brand name VILTEPSO® – for the treatment of Duchenne muscular ...

4. • 

     The Petri Dish: Dyne’s public offering, Kronos’ new CFO - Boston Business Journal

     The Business Journals· 5 days ago

     At the start of this week, Waltham’s Dyne Therapeutics Inc. had positive news to share on two...

5. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 9 hours ago

     Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2023 with fully audited results for the year ended December 31, 2023. Santhera

6. • 

     Becker muscular dystrophy age of onset: Research and more

     Medical News Today· 6 days ago

     BMD is a type of recessive muscular dystrophy that usually affects male children. It occurs due to a...

7. • 

     Up 165% This Year, Will Dyne Therapeutics Continue Its Stellar Run?

     Forbes· 6 days ago

     This move came in after the company released a positive clinical trial data for its experimental...

8. • 

     Muscular dystrophy prevention, outlook, and slowing progression

     Medical News Today· 5 days ago

     A person may inherit the genetic changes responsible for muscular dystrophy. Muscular dystrophies...

9. • 

     Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

     Zacks via Yahoo Finance· 5 days ago

     Following the decision, the EC has returned the opinion to the CHMP for re-evaluation. Thus, in the...

10. • 

      Grandmother earns honorary degree after helping grandson graduate from UCO

      KOKH FOX 25· 6 days ago

      A grandmother in Edmond now has an honorary degree from the University of Central Oklahoma (UCO)....